Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mechanistic Target of Rapamycin complex 1 (mTORC1) senses intracellular amino acid levels through an intricate machinery, which includes the Rag GTPases, Ragulator and vacuolar ATPase (V-ATPase). The membrane-associated E3 ubiquitin ligase
ZNRF2
is released into the cytosol upon its phosphorylation by Akt. In this study, we show that
ZNRF2
interacts with
mTOR
on membranes, promoting the amino acid-stimulated translocation of mTORC1 to lysosomes and its activation in human cells.
ZNRF2
also interacts with the V-ATPase and preserves lysosomal acidity. Moreover, knockdown of
ZNRF2
decreases cell size and cell proliferation. Upon growth factor and amino acid stimulation, mTORC1 phosphorylates
ZNRF2
on Ser145, and this phosphosite is dephosphorylated by protein phosphatase 6. Ser145 phosphorylation stimulates vesicle-to-cytosol translocation of
ZNRF2
and forms a novel negative feedback on mTORC1. Our findings uncover
ZNRF2
as a component of the amino acid sensing machinery that acts upstream of Rag-GTPases and the V-ATPase to activate mTORC1.
...
PMID:The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids. 2724 71